International Journal of Epidemiology 2002;31:59-70
© International Epidemiological Association 2002
Special Theme: Systematic Reviews and Meta-Analysis |
Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies
a Division of Nutrition and Physical Activity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
b Division of Environmental Health Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
c Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA, USA.
d Office of Women's Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
e Division of Environmental Health Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
E Ford, Division of Nutrition and Physical Activity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, MS K24, Atlanta, GA 30341, USA.
Abstract
Background Elevated concentrations of homocyst(e)ine are thought to increase the risk of vascular diseases including coronary heart disease and cerebrovascular disease.
Methods We searched MEDLINE (1966–1999), EMBASE (1974–1999), SciSearch (1974– 1999), and Dissertation Abstracts (1999) for articles and theses about homocyst(e)ine concentration and coronary heart disease and cerebrovascular disease.
Results We included 57 publications (3 cohort studies, 12 nested case-control studies, 42 case-control studies) that reported results on 5518 people with coronary heart disease (11 068 control subjects) and 1817 people with cerebrovascular disease (4787 control subjects) in our analysis. For coronary heart disease, the summary odds ratios (OR) for a 5-µmol/l increase in homocyst(e)ine concentration were 1.06 (95% CI : 0.99–1.13) for 2 publications of cohort studies, 1.23 (95% CI : 1.07–1.41) for 10 publications of nested case-control studies, and 1.70 (95% CI : 1.50–1.93) for 26 publications of case-control studies. For cerebrovascular disease, the summary OR for a 5-µmol/l increase in homocyst(e)ine concentration were 1.10 (95% CI : 0.94–1.28) for 2 publications of cohort studies, 1.58 (95% CI : 1.35–1.85) for 5 publications of nested case-control studies, and 2.16 (95% CI : 1.65–2.82) for 17 publications of case-control studies.
Conclusions Prospective studies offer weaker support than case-control studies for an association between homocyst(e)ine concentration and cardiovascular disease. Although other lines of evidence support a role for homocyst(e)ine in the pathogenesis of cardiovascular disease, more information from prospective epidemiological studies or clinical trials is needed to clarify this role.
Keywords Homocyst(e)ine, meta-analysis, cardiovascular disease
Accepted 4 April 2001
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Ranucci, A. Ballotta, A. Frigiola, A. Boncilli, S. Brozzi, E. Costa, and R. H. Mehta Pre-operative homocysteine levels and morbidity and mortality following cardiac surgery Eur. Heart J., April 2, 2009; 30(8): 995 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. B Imasa, N. T Gomez, and J. B Nevado Jr Folic Acid-Based Intervention in Non-ST Elevation Acute Coronary Syndromes Asian Cardiovasc Thorac Ann, January 1, 2009; 17(1): 13 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-C. Weng, W.-T. Yeh, C.-H. Bai, H.-J. Chen, S.-Y. Chuang, H.-Y. Chang, B.-F. Lin, K.-J. Chen, and W.-H. Pan Is Ischemic Stroke Risk Related to Folate Status or Other Nutrients Correlated With Folate Intake? Stroke, December 1, 2008; 39(12): 3152 - 3158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Wei Hsi Chen, Hung Sheng Lin, Yi Fen Kao, Min Yu Lan, and Jia Shou Liu Hyperhomocysteinemia Relates to the Subtype of Antiphospholipid Antibodies in Non-SLE Patients Clinical and Applied Thrombosis/Hemostasis, October 1, 2007; 13(4): 398 - 403. [Abstract] [PDF]
|
|
|
|
 |
|
 A. S Wierzbicki Homocysteine and cardiovascular disease: a review of the evidence Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 143 - 149. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Y.L. Zee, S. Mora, S. Cheng, H. A. Erlich, K. Lindpaintner, N. Rifai, J. E. Buring, and P. M Ridker Homocysteine, 5,10-Methylenetetrahydrofolate Reductase 677C>T Polymorphism, Nutrient Intake, and Incident Cardiovascular Disease in 24 968 Initially Healthy Women Clin. Chem., May 1, 2007; 53(5): 845 - 851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Vanuzzo, L. Pilotto, R. Lombardi, G. Lazzerini, M. Carluccio, S. Diviacco, F. Quadrifoglio, G. Danek, D. Gregori, P. Fioretti, et al. Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects Eur. Heart J., February 2, 2007; 28(4): 484 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Ruiz, R. Sola, M. Gonzalez-Gross, F. B. Ortega, G. Vicente-Rodriguez, M. Garcia-Fuentes, A. Gutierrez, M. Sjostrom, K. Pietrzik, and M. J. Castillo Cardiovascular Fitness Is Negatively Associated With Homocysteine Levels in Female Adolescents Arch Pediatr Adolesc Med, February 1, 2007; 161(2): 166 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Hayden, P. Cote, and C. Bombardier Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med, March 21, 2006; 144(6): 427 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Prepared by: British Cardiac Society, British Hype JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice Heart, December 1, 2005; 91(suppl_5): v1 - v52. [Full Text] [PDF]
|
|
|
|
 |
|
 S. J Lewis, S. Ebrahim, and G. Davey Smith Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ, November 5, 2005; 331(7524): 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cesari, M. Zanchetta, A. Burlina, L. Pedon, G. Maiolino, D. Sticchi, A. C. Pessina, and G. P. Rossi Hyperhomocysteinemia Is Inversely Related With Left Ventricular Ejection Fraction and Predicts Cardiovascular Mortality in High-Risk Coronary Artery Disease Hypertensives Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 115 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W.F. Wilson CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Ability of Inflammatory Markers to Predict Disease in Asymptomatic Patients: A Background Paper Circulation, December 21, 2004; 110(25): e568 - e571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Voutilainen, J. K Virtanen, T. H Rissanen, G. Alfthan, J. Laukkanen, K. Nyyssonen, J. Mursu, V.-P. Valkonen, T.-P. Tuomainen, G. A Kaplan, et al. Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study Am. J. Clinical Nutrition, August 1, 2004; 80(2): 317 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Hankey and J. W. Eikelboom Folic Acid-Based Multivitamin Therapy to Prevent Stroke: The Jury Is Still Out Stroke, August 1, 2004; 35(8): 1995 - 1998. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gonzalez, J. M. Huerta, J. Alvarez-Uria, S. Fernandez, A. M. Patterson, and C. Lasheras Serum Selenium Is Associated with Plasma Homocysteine Concentrations in Elderly Humans J. Nutr., July 1, 2004; 134(7): 1736 - 1740. [Abstract] [Full Text]
|
|
|
|
|
|
H. Iso, Y. Moriyama, S. Sato, A. Kitamura, T. Tanigawa, K. Yamagishi, H. Imano, T. Ohira, T. Okamura, Y. Naito, et al. Serum Total Homocysteine Concentrations and Risk of Stroke and Its Subtypes in Japanese Circulation, June 8, 2004; 109(22): 2766 - 2772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bauer, A. C. Hamm, M. Bonaus, A. Jacob, J. Jaekel, H. Schorle, M. J. Pankratz, and J. D. Katzenberger Starvation response in mouse liver shows strong correlation with life-span-prolonging processes Physiol Genomics, April 13, 2004; 17(2): 230 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Gao, O. I. Bermudez, and K. L. Tucker Plasma C-Reactive Protein and Homocysteine Concentrations Are Related to Frequent Fruit and Vegetable Intake in Hispanic and Non-Hispanic White Elders J. Nutr., April 1, 2004; 134(4): 913 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Zylberstein, C. Bengtsson, C. Bjorkelund, S. Landaas, V. Sundh, D. Thelle, and L. Lissner Serum Homocysteine in Relation to Mortality and Morbidity From Coronary Heart Disease: A 24-Year Follow-Up of the Population Study of Women in Gothenburg Circulation, February 10, 2004; 109(5): 601 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Gao, M. Yao, M. A. McCrory, G. Ma, Y. Li, S. B. Roberts, and K. L. Tucker Dietary Pattern Is Associated with Homocysteine and B Vitamin Status in an Urban Chinese Population J. Nutr., November 1, 2003; 133(11): 3636 - 3642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Hackam and S. S. Anand Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence JAMA, August 20, 2003; 290(7): 932 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. El-Khairy, S. E. Vollset, H. Refsum, and P. M. Ueland Plasma Total Cysteine, Mortality, and Cardiovascular Disease Hospitalizations: The Hordaland Homocysteine Study Clin. Chem., June 1, 2003; 49(6): 895 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Kim, J. M. Ordovas, J. Selhub, and H. Campos B Vitamins and Plasma Homocysteine Concentrations in an Urban and Rural Area of Costa Rica J. Am. Coll. Nutr., June 1, 2003; 22(3): 224 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. B. Fallon, J. Virtamo, I. Young, D. McMaster, Y. Ben-Shlomo, N. Wood, A. S. Whitehead, and G. D. Smith Homocysteine and Cerebral Infarction in Finnish Male Smokers Stroke, June 1, 2003; 34(6): 1359 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Boysen, T. Brander, H. Christensen, R. Gideon, and T. Truelsen Homocysteine and Risk of Recurrent Stroke Stroke, May 1, 2003; 34(5): 1258 - 1261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Ganji and M. R Kafai Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994 Am. J. Clinical Nutrition, April 1, 2003; 77(4): 826 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ay, E. M. Arsava, S. L. Tokgozoglu, N. Ozer, and O. Saribas Hyperhomocysteinemia Is Associated With the Presence of Left Atrial Thrombus in Stroke Patients With Nonvalvular Atrial Fibrillation Stroke, April 1, 2003; 34(4): 909 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Nagata, H. Shimizu, R. Takami, M. Hayashi, N. Takeda, and K. Yasuda Soy Product Intake Is Inversely Associated with Serum Homocysteine Level in Premenopausal Japanese Women J. Nutr., March 1, 2003; 133(3): 797 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Tanne, M. Haim, U. Goldbourt, V. Boyko, R. Doolman, Y. Adler, D. Brunner, S. Behar, and B.-A. Sela Prospective Study of Serum Homocysteine and Risk of Ischemic Stroke Among Patients With Preexisting Coronary Heart Disease Stroke, March 1, 2003; 34(3): 632 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. B. Fallon, Y. Ben-Shlomo, P.J. Kelly, J. Rosand, V. Shih, J. Kistler, and K.L. Furie Homocysteine, MTHFR 677C->T polymorphism, and risk of ischemic stroke: Results of a meta-analysis Neurology, February 11, 2003; 60(3): 526 - 527. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Davey Smith and S. Ebrahim 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol., February 1, 2003; 32(1): 1 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Venn, A. M. Grant, C. D. Thomson, and T. J. Green Selenium Supplements Do Not Increase Plasma Total Homocysteine Concentrations in Men and Women J. Nutr., February 1, 2003; 133(2): 418 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. El-Khairy, S. E. Vollset, H. Refsum, and P. M. Ueland Predictors of Change in Plasma Total Cysteine: Longitudinal Findings from the Hordaland Homocysteine Study Clin. Chem., January 1, 2003; 49(1): 113 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Lim and P. A. Cassano Homocysteine and Blood Pressure in the Third National Health and Nutrition Examination Survey, 1988-1994 Am. J. Epidemiol., December 15, 2002; 156(12): 1105 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Bree, W. M. M. Verschuren, D. Kromhout, L. A. J. Kluijtmans, and H. J. Blom Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease Pharmacol. Rev., December 1, 2002; 54(4): 599 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. De Bree, W. M. Verschuren, D. Kromhout, L. I Mennen, H. J Blom, E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, et al. Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects Int. J. Epidemiol., December 1, 2002; 31(6): 1268 - 1272. [Full Text] [PDF]
|
|
|
|
|
|
M. Egger, S. Ebrahim, and G. D. Smith Where now for meta-analysis? Int. J. Epidemiol., February 1, 2002; 31(1): 1 - 5. [Full Text] [PDF]
|
|
|
|
|
|
K. Dickersin Systematic reviews in epidemiology: why are we so far behind? Int. J. Epidemiol., February 1, 2002; 31(1): 6 - 12. [Full Text] [PDF]
|
|
|
|
|
|
R. Clarke Commentary: An updated review of the published studies of homocysteine and cardiovascular disease Int. J. Epidemiol., February 1, 2002; 31(1): 70 - 71. [Full Text] [PDF]
|
|